Drug Shortage Report for MAXITROL
Report ID | 158484 |
Drug Identification Number | 00042676 |
Brand name | MAXITROL |
Common or Proper name | MAXITROL SUSP. 5ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | POLYMYXIN B SULFATE NEOMYCIN DEXAMETHASONE |
Strength(s) | 6000UNIT 3.5MG 0.1% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01CA |
ATC description | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-05-09 |
Actual start date | |
Estimated end date | 2022-06-14 |
Actual end date | 2022-06-16 |
Shortage status | Resolved |
Updated date | 2022-06-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-06-17 | English | Compare |
v13 | 2022-06-16 | French | Compare |
v12 | 2022-06-16 | English | Compare |
v11 | 2022-06-16 | French | Compare |
v10 | 2022-06-16 | English | Compare |
v9 | 2022-06-06 | French | Compare |
v8 | 2022-06-06 | English | Compare |
v7 | 2022-05-10 | English | Compare |
v6 | 2022-04-29 | French | Compare |
v5 | 2022-04-29 | English | Compare |
v4 | 2022-04-29 | English | Compare |
v3 | 2022-04-25 | English | Compare |
v2 | 2022-04-11 | French | Compare |
v1 | 2022-04-11 | English | Compare |
Showing 1 to 14 of 14